Analysis of Exosome Therapeutics market Strategies and Forecasts to 2035

Driven by the development of novel platforms and advanced technologies along with consistent efforts of the stakeholders in research and development of exosome therapeutics which is set to see some FDA approved therapies in this decade

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

  • Type of Therapeutic
  • Allogeneic Therapy
  • AutologousTherapy
  • Target Indication(s)
  • Degenerative Meniscal Injury
  • Dystrophic Epidermolysis Bullosa
  • Fistula Perianal
  • Retinitis Pigmentosa
  • Therapeutic Area
  • Dermatological Disorders
  • Muscoskeletal Disorders
  • Ophthalmic Diseases
  • Rectal Disorders
  • Route of Administration
  • Fistula Tract
  • Intra-articular
  • Intra-ocular
  • Geography
  • North America
  • Europe
  • Asia-Pacific and Rest of the World

TheExosome Therapeutics Market, 2022-2040 report features the following companies, which we identified to be key players in this domain:

  • Codiak BioSciences
  • Coya Therapeutics
  • Curexsys
  • EV Therapeutics
  • Evox Therapeutics
  • AEGLE Therapeutics
  • AVEM Healthcare
  • Cellular Biomedicine Group
  • OBCTCD24
  • ReNeuron
  • Stem Cell Medicine

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape

5. Company Profiles

6. Drug Profiles

7. Clinical Trial Analysis 

8. Academic Grants Analysis

9. Global Event Analysis

10. Partnerships and Collaborations

11. Funding and Investments

12. Start-up Health Indexing

13. Case Study: Exosome Development and Manufacturing Service Providers

14. Drug Failure Analysis

15. Market Forecast

16. Executive Insights

17. Appendix 1: Tabulated Data

18. Appendix 2: List of Companies and Organizations

Key Questions Answered

  • Who are the leading industry and non-industry players engaged in the development of exosome therapy?
  • Which are the key drugs being developed across early and late stages of development?
  • What are the key agendas being discussed in various global events / conferences related to exosomes?
  • What kind of partnership models are commonly adopted by industry stakeholders?
  • Which are the leading funding institutes / centers supporting the research related to exosome therapies?
  • Which geographies are the most active in conducting clinical trials related to exosome therapeutics?
  • How is the current and future market opportunity, related to exosome therapies likely to be distributed across key market segments?

To view more details on this report, click on the link

News article

Smart Pharmaceutical and Healthcare Labels Market

Learn from experts:  do you know about these emerging industry trends?

Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities

Digital Therapies: The “Digital Pills” of current generation

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services: 

Roots Analysis Consulting – the preferred research partner for global firms


Ben Johnson

+1 (415) 800 3415

[email protected]


Leave a Reply

Your email address will not be published. Required fields are marked *